Top Markets
Coin of the day
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Peringkat dalam Saham #17188
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Harga Saham
$2.17
Kapitalisasi Pasar
$249.58M
Perubahan (1 hari)
-1.67%
Perubahan (1 tahun)
96.34%
Negara
CA
Perdagangan Cardiol Therapeutics Inc. (CRDL)

Kategori

Riwayat harga saham Cardiol Therapeutics Inc. (CRDL)
Harga penutupan tertinggi: $2.19 pada 2026-09-01

Harga penutupan terendah: $3.27 pada 2018-12-01
Riwayat harga saham Cardiol Therapeutics Inc. dari 2018 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) 17.16%
2025 -27.01%
2024 53.46%
2023 55.10%
2022 -70.87%
2021 -2.95%
2020 -34.16%
2019 -4.78%
2018 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$171.67 -
DE
$165.71 31.84%
DE
$38.13 25.43%
JP
$21.28 19.62%
IN
$214.46 25.80%
CH